METHOD FOR PRODUCING NOVEL HIPSC BY MEANS OF SIRNA INTRODUCTION
外国特許コード | F120006420 |
---|---|
整理番号 | H22-007a-2 |
掲載日 | 2012年4月11日 |
出願国 | 世界知的所有権機関(WIPO) |
国際出願番号 | 2011JP064846 |
国際公開番号 | WO 2012/008301 |
国際出願日 | 平成23年6月28日(2011.6.28) |
国際公開日 | 平成24年1月19日(2012.1.19) |
優先権データ |
|
発明の名称 (英語) |
METHOD FOR PRODUCING NOVEL HIPSC BY MEANS OF SIRNA INTRODUCTION
|
発明の概要(英語) | Disclosed is a novel compound which induces pluripotent stem cells. Also disclosed is a novel anti-malignant tumor substance. Specifically disclosed is a pluripotent stem cell inducer for inducing cells into pluripotent stem cells, which contains one or more kinds of single-stranded polynucleotides or double-stranded polynucleotides that are selected from the group consisting of: (a) a single-stranded polynucleotide or double-stranded polynucleotide that comprises the nucleotide sequence set forth in SEQ ID NO: 1 or a nucleotide sequence that is produced by deleting, substituting or adding one to three nucleotides in the nucleotide sequence set forth in SEQ ID NO: 1; (b) a single-stranded polynucleotide or double-stranded polynucleotide that comprises the nucleotide sequence set forth in SEQ ID NO: 2 or a nucleotide sequence that is produced by deleting, substituting or adding one to three nucleotides in the nucleotide sequence set forth in SEQ ID NO: 2; and (c) a single-stranded polynucleotide or double-stranded polynucleotide that comprises the nucleotide sequence set forth in SEQ ID NO: 3 or a nucleotide sequence that is produced by deleting, substituting or adding one to three nucleotides in the nucleotide sequence set forth in SEQ ID NO: 3. |
|
|
|
|
国際特許分類(IPC) |
|
指定国 | AE(UTILITY MODEL),AG,AL(UTILITY MODEL),AM(PROVISIONAL PATENT)(UTILITY MODEL),AO(UTILITY MODEL),AT(UTILITY MODEL),AU,AZ(UTILITY MODEL),BA(CONSENSUAL PATENT),BB,BG(UTILITY MODEL),BH(UTILITY MODEL),BR(UTILITY MODEL),BW,BY(UTILITY MODEL),BZ(UTILITY MODEL),CA,CH,CL(UTILITY MODEL),CN(UTILITY MODEL),CO(UTILITY MODEL),CR(UTILITY MODEL),CU(INVENTOR'S CERTIFICATE),CZ(UTILITY MODEL),DE(UTILITY MODEL),DK(UTILITY MODEL),DM,DO(UTILITY MODEL),DZ,EC(UTILITY MODEL),EE(UTILITY MODEL),EG(UTILITY MODEL),ES(UTILITY MODEL),FI(UTILITY MODEL),GB,GD,GE(UTILITY MODEL),GH(UTILITY CERTIFICATE),GM,GT(UTILITY MODEL),HN(UTILITY MODEL),HR(CONSENSUAL PATENT),HU(UTILITY MODEL),ID,IL,IN,IS,JP(UTILITY MODEL),KE(UTILITY MODEL),KG(UTILITY MODEL),KM,KN,KP(INVENTOR'S CERTIFICATE)(UTILITY MODEL),KR(UTILITY MODEL),KZ(PROVISIONAL PATENT)(UTILITY MODEL),LA,LC,LK,LR,LS(UTILITY MODEL),LT,LU,LY,MA,MD(UTILITY MODEL),ME,MG,MK,MN,MW,MX(UTILITY MODEL),MY(UTILITY-INNOVATION),MZ(UTILITY MODEL),NA,NG,NI(UTILITY MODEL),NO,NZ,OM(UTILITY MODEL),PE(UTILITY MODEL),PG,PH(UTILITY MODEL),PL(UTILITY MODEL),PT(UTILITY MODEL),RO,RS(PETTY PATENT),RU(UTILITY MODEL),SC,SD,SE,SG,SK(UTILITY MODEL),SL(UTILITY MODEL),SM,ST,SV(UTILITY MODEL),SY,TH(PETTY PATENT),TJ(UTILITY MODEL),TM(PROVISIONAL PATENT),TN,TR(UTILITY MODEL),TT(UTILITY CERTIFICATE),TZ,UA(UTILITY MODEL),UG(UTILITY CERTIFICATE),US,UZ(UTILITY MODEL),VC(UTILITY CERTIFICATE),VN(PATENT FOR UTILITY SOLUTION),ZA,ZM,ZW,EP(AL,AT,BE,BG,CH,CY,CZ,DE,DK,EE,ES,FI,FR,GB,GR,HR,HU,IE,IS,IT,LT,LU,LV,MC,MK,MT,NL,NO,PL,PT,RO,RS,SE,SI,SK,SM,TR),OA(BF(UTILITY MODEL),BJ(UTILITY MODEL),CF(UTILITY MODEL),CG(UTILITY MODEL),CI(UTILITY MODEL),CM(UTILITY MODEL),GA(UTILITY MODEL),GN(UTILITY MODEL),GQ(UTILITY MODEL),GW(UTILITY MODEL),ML(UTILITY MODEL),MR(UTILITY MODEL),NE(UTILITY MODEL),SN(UTILITY MODEL),TD(UTILITY MODEL),TG(UTILITY MODEL)),AP(BW(UTILITY MODEL),GH(UTILITY MODEL),GM(UTILITY MODEL),KE(UTILITY MODEL),LR(UTILITY MODEL),LS(UTILITY MODEL),MW(UTILITY MODEL),MZ(UTILITY MODEL),NA(UTILITY MODEL),SD(UTILITY MODEL),SL(UTILITY MODEL),SZ(UTILITY MODEL),TZ(UTILITY MODEL),UG(UTILITY MODEL),ZM(UTILITY MODEL),ZW(UTILITY MODEL)),EA(AM,AZ,BY,KG,KZ,MD,RU,TJ,TM) |
日本語項目の表示
発明の名称 |
siRNA導入による新規hiPSC作製法
|
---|---|
発明の概要 | 多能性幹細胞を誘導する新規の化合物を明らかにする。新しい抗悪性腫瘍物質を明らかにする。 a)配列番号1の塩基配列、またはその塩基配列に対して1~3個の塩基が欠失、置換もしくは付加された塩基配列、を含む、1本鎖または2本鎖のポリヌクレオチド、b)配列番号2の塩基配列、またはその塩基配列に対して1~3個の塩基が欠失、置換もしくは付加された塩基配列、を含む、1本鎖または2本鎖のポリヌクレオチド、c)配列番号3の塩基配列、またはその塩基配列に対して1~3個の塩基が欠失、置換もしくは付加された塩基配列、を含む、1本鎖または2本鎖のポリヌクレオチド、からなる群から選ばれる1種以上の1本鎖または2本鎖のポリヌクレオチドを含有し、細胞を多能性幹細胞へ誘導する、多能性幹細胞誘導剤を提供する。 |
※
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記「問合せ先」まで直接お問い合わせください。
『 METHOD FOR PRODUCING NOVEL HIPSC BY MEANS OF SIRNA INTRODUCTION 』に関するお問合せ
- 国立大学法人 鳥取大学 産学・地域連携推進機構 知的財産管理運用部門
- URL: http://www2.cjrd.tottori-u.ac.jp/
-
E-mail:
- Address: 〒680-8550 鳥取県鳥取市湖山町南4丁目101
- TEL: 0857-31-6000
- FAX: 0857-31-5474